Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT05937620

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Led by Fundacion Clinic per a la Recerca Biomédica · Updated on 2026-02-09

62

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.

CONDITIONS

Official Title

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with adnexal mass diagnosed with high suspicion of malignancy undergoing intraoperative biopsy or patients with early-stage epithelial ovarian cancer confirmed by pathology with complete staging indicated.
  • No evidence of lymph node involvement or metastatic disease based on preoperative imaging.
  • Signed informed consent from the patient or responsible relative.
  • Women with childbearing potential must agree to use highly effective contraception methods until the study ends.
Not Eligible

You will not qualify if you...

  • Patients younger than 18 years.
  • Pregnant or breastfeeding women.
  • Epithelial ovarian tumors at FIGO stage III or IV.
  • Unable to obtain a biopsy from the tumor.
  • History of vascular surgery (cava vein, aorta, iliac vessels) or radiotherapy in pelvic or para-aortic area.
  • Sentinel lymph node biopsy will not be performed if intraoperative histology shows benign ovarian tumor, low malignancy potential tumor, or expansive mucinous histology.
  • Patients unable to undergo surgery.
  • Hypersensitivity to the active tracer, sodium iodide, or iodine allergy.
  • Patients with clinical hyperthyroidism, thyroid autonomous adenomas, or focal/diffuse autonomous thyroid gland alterations.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Laura Burunat

Barcelona, Catalonia, Spain, 08036

Actively Recruiting

Loading map...

Research Team

L

Laura Burunat, Graduate

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here